All Posts: clinical trials
38 Articles
- GUMC Stories
More Young People Are Getting Colon Cancer Than Ever. This Doctor Is Accelerating Clinical Trials To Find New Treatments
Colorectal cancer rates in adults under 50 are surging. Georgetown's Dr. John Marshall is accelerating clinical trials to bring new treatments to.…
September 21, 2026
- News Release
Georgetown Investigator Presents Final PAPILLON Trial Results Showing Long-Term Survival in a Subset of Lung Cancer
Final results from the landmark PAPILLON trial, which changed the standard of care for a difficult-to-treat rare form of lung cancer, confirm that amivantamab, when added to…
September 14, 2026
- GUMC Stories
Promising Phase III Melanoma Results Build on Research Conducted at Georgetown Lombardi
A promising new approach to preventing high-risk melanoma from recurring after surgery has yielded positive results in a large clinical trial, building on earlier research that…
August 19, 2026
- News Release
Preoperative Dual Immunotherapy Combination Shows Promising Activity in High-Risk Early-Stage HER2-Negative Breast Cancer
A combination of two immunotherapy drugs showed encouraging activity when added to standard chemotherapy given prior to surgery for patients with high-risk, early-stage HER2…
July 30, 2026
- News Release
Georgetown University Opens Advanced Study for Huntington’s Disease
Georgetown University Medical Center has launched a new clinical research opportunity for people diagnosed with Huntington’s disease (HD) who are experiencing the early symptoms…
June 24, 2026
- News Release
Clinical Study Deepens Understanding of Mesothelioma and Opens the Door to Potential Treatment Options
People with operable diffuse pleural mesothelioma may benefit from immunotherapy before and after surgery, based on results of a clinical trial exploring the sequence of…
September 8, 2025
- News Release
Investigational Drug Shows Promise in a Clinical Trial for Lung Cancers With ALK Mutations
Early signals from phase 1 of the ALKOVE-1 clinical trial suggest potential benefit from the use of an investigational drug called NVL-655 in people whose non-small cell lung…
November 8, 2024
- GUMC Stories
ISPY2: A Unique, Flexible Breast Cancer Trial for Modern Times
The ISPY2 breast cancer clinical trial is a unique phase 2 study that offers a broad range of treatment options for patients with locally advanced breast.…
August 16, 2024
- News Release
Experimental Therapy Shows Promise in Pancreatic Cancer Clinical Trial
Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic…
June 1, 2024
- News Release
The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other…
April 29, 2024